Clinical trial being conducted in children complaining of irregular menstrual cycle and related issues

A FURTHER CLINICAL STUDY ON GRAHANI DOSHA AND ITS MANAGEMENT WITH DEVDARVYADI VATI AND BHUNIMBADI VATI IN CHILDREN

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/07/006037

Enrollment

Registered

2015-07-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Irregular Mala Pravritti , Udarashula

Interventions

Intervention1: Group:B BHUNIMBADI VATI: DOSE 3gm ,3.5gm,4gm,5gm,5.5gm,6gm (As per age) Dosage form: Vati(Each Vati is of 500 mg) Duration : 4 Weeks, Route of administration :Oral, Time of administrati

Eligibility

Inclusion criteria

Inclusion criteria: (Any two or more among it) 1)Age : 5 -10 years of both sex 2) Irregular Mala Pravritti 3) Udarashula 4) Balakshaya 5) Avipaka

Exclusion criteria

Exclusion criteria: 1)Age: below 5 years and above 10 years. 2)Having infestation and infectious disease. 3)Congenital anomalies 4)Hereditary diseases.

Design outcomes

Primary

Measure	Time frame
On the basis of improvement in the Irregular Mala PravritiTimepoint: 2 Weeks	—

Secondary

Measure	Time frame
On basis of improvement in the clinical signs and symptoms and investigations Timepoint: 2 Weeks	—

Countries

India

Contacts

Public ContactDr RAJAGOPALA S

INSTITUTE FOR POST GRADUATE TEACHING AND RESEARCH IN AYURVEDA GUJARAT AYURVED UNIVERSITY JAMNAGAR

drkspatel2007@yahoo.co.in09427574566

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026